NCT02666820

Brief Summary

Endoscopic sphincterotomy (EST) combined with large balloon dilation (LBD) has been increasingly accepted as alternative method for removal of large bile duct stones. However, there were limited studies comparing the efficacy of EST in combined with LBD to EST with mechanical lithotripsy (ML). The purpose of this study to compare the efficacy and safety of combined EST- LBD versus EST-ML in the removal of very large bile duct stones.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

January 25, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 28, 2016

Completed
Last Updated

January 29, 2016

Status Verified

January 1, 2016

Enrollment Period

2.4 years

First QC Date

January 25, 2016

Last Update Submit

January 28, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Complete stone clearance rate in the index ERCP

    The number of patients who was achieved complete stone clearance in the index ERCP

    24 hours

Secondary Outcomes (3)

  • Procedure time

    24 hours

  • Complete stone clearance rate in the rescue therapy

    24 hours

  • Complication rate

    30 days

Study Arms (2)

Large balloon dilatation

ACTIVE COMPARATOR

Patients underwent clearance of common bile duct stones using a papillary large balloon dilatation.

Procedure: Large balloon dilatation

Mechanical lithotripsy

ACTIVE COMPARATOR

Patients underwent clearance of common bile duct stones using a mechanical lithotripsy.

Procedure: Mechanical lithotripsy

Interventions

After biliary sphincterotomy was performed with full extension to the full length of transverse fold. A 12, 15, 18 or 20 mm CRE-balloon was passed over guide wire and position across the papilla. The balloon was gradually inflated to the largest size of the bile duct stone and/or the bile duct diameter. When complete stone removal was unsuccessful , crossing over treatment was considered at the discretion of the endoscopists.

Large balloon dilatation

After biliary sphincterotomy was performed with full extension to the full length of transverse fold. A 3x6 cm Trapezoid Rx retrieval stone basket was used to capture the stone and crushing of stones was done when simple stone extraction failed to remove the stone. The stone fragments were then retrieved with a basket and/ or a retrieval balloon. When complete stone removal was unsuccessful , crossing over treatment was considered at the discretion of the endoscopists.

Mechanical lithotripsy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent was obtained in every patients prior to the procedure
  • Patients were randomized to LBD or ML if they had CBD stone \>/= 15 mm in shortest dimension or stone' size was disproportionate to the lower bile duct segment with a ratio of largest stone dimension/lower bile duct segment diameter \> 50 % identified by a cholangiogram at ERCP.

You may not qualify if:

  • uncorrectable coagulopathy (INR \>1.5 ), thrombocytopenia( platelet count \< 50,000)
  • concomitant intrahepatic duct stones
  • ongoing acute pancreatitis or acute cholecystitis
  • surgically altered anatomy (i.e. Billroth II or Roux-en-Y reconstruction)
  • concomitant pancreatic or biliary malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NKC Institue of Gastroenterology and Hepatology, Prince of Songkla University

Hat Yai, Changwat Songkhla, 90110, Thailand

Location

Study Officials

  • Bancha Ovartlarnporn, MD.

    NKC Institute of Gastroenterology and Hepatology, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla, Thailand, 90110.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 25, 2016

First Posted

January 28, 2016

Study Start

December 1, 2010

Primary Completion

May 1, 2013

Study Completion

May 1, 2014

Last Updated

January 29, 2016

Record last verified: 2016-01

Data Sharing

IPD Sharing
Will not share

The individual data of patients participating in the study are not available for public sharing since we did not obtain the consent to share the data of patient

Locations